The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Sep 2016 10:42

RNS Number : 6794K
Premaitha Health PLC
23 September 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Premaitha Health plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

ü

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Life Technologies Limited, a company incorporated in Scotland with company number SC083107

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

22 September 2016

6. Date on which issuer notified:

23 September 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 9% and through 9%, 10%, 11%, 12% and 13%

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Warrants

24.6p

11 December 2023

Exercisable up to 11 December 2023

 

20,325,204

Nominal

Delta

8.9% (based on current share capital) and 7.07% (based on so-enlarged share capital)

 

Warrants

11.7p

11 December 2023

Exercisable up to 11 December 2023

 

17,094,018

Nominal

7.5% (based on current share capital) and 5.95% (based on so-enlarged share capital)

Delta

 

 

 

 

 

 

 

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,419,222

16.4% (based on current share capital) and 13.03% (based on so-enlarged share capital).

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Life Technologies Limited is a controlled undertaking of Thermo Fisher Scientific Inc. a company incorporated in the United States of America.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Ted Fong

15. Contact telephone number:

001 (650) 244-1616

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOSKRNRAKURR
Date   Source Headline
7th Jul 20097:00 amRNSContract Win
23rd Jun 20093:06 pmRNSAdditional Listing
12th Jun 200910:55 amRNSBoard Change
1st Jun 200912:39 pmRNSExercise of Options & TVR
11th May 20094:10 pmRNSHolding(s) in Company
6th May 20094:04 pmRNSTrading Statement
5th May 20094:13 pmRNSHolding(s) in Company
5th May 20093:24 pmRNSExercise of Warrants
5th May 20097:00 amRNSTrading Statement
23rd Apr 20098:55 amRNSTrading Statement
21st Apr 200912:50 pmRNSResult of Warrantholder General Meeting
16th Apr 20098:49 amRNSTrading Statement
6th Apr 200911:56 amRNSHolding(s) in Company
2nd Apr 20097:00 amRNSIssue of Equity
1st Apr 20098:10 amRNSTrading Statement
23rd Mar 20097:00 amRNSTrading Statement
4th Mar 20091:33 pmRNSHolding(s) in Company
16th Jan 20098:31 amRNSTrading Statement
18th Dec 20089:19 amRNSWarrant Update
16th Dec 20087:00 amRNSTrading Statement
16th Dec 20087:00 amRNSHalf Yearly Report
29th Oct 200812:47 pmRNSResult of AGM
29th Oct 20087:00 amRNSOil Well Update
22nd Oct 20087:00 amRNSOil Exploration Drilling in Texas
7th Oct 200810:55 amRNSCancellation and re-issue of options
30th Sep 20087:00 amRNSFinal Results
29th Sep 20087:00 amRNSProjects Update
10th Sep 20089:00 amRNSHolding(s) in Company
1st Sep 200811:12 amRNSTotal Voting Rights
19th Aug 20084:14 pmRNSHolding(s) in Company
19th Aug 200812:40 pmRNSPlacing raises GBP1.8 million
18th Aug 200810:07 amRNSContract with ASTFS
14th Aug 200811:07 amRNSStrategic Agreement with Swan
6th Aug 20087:00 amRNSLA County Radiation Monitorin
21st Jul 20087:00 amRNSUpdate on Oil Reservoir Analy
17th Jul 20082:26 pmRNSHolding(s) in Company
1st Jul 20087:00 amRNSPartners with Texas group AST
18th Jun 20087:00 amRNSPartners with Atascosa Explor
29th May 20087:00 amRNSContract Win
1st Apr 20081:00 pmRNSViaLogy selected by Cisco
13th Mar 20082:10 pmRNSAdditional Listing
8th Feb 200810:02 amRNSAppointment of Broker
7th Feb 20087:00 amRNSProduct approval in US
30th Jan 20087:01 amRNSSenior Appointment
27th Dec 20077:00 amRNSInterim Results
30th Nov 20077:11 amRNSSenior appointment
30th Oct 20074:13 pmRNSResult of AGM
30th Oct 200710:02 amRNSAGM Statement
25th Oct 200710:59 amRNSGrant of options
28th Sep 20074:15 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.